Total Payments
$1.5M
2024 Payments
$91,863
Companies
26
Transactions
1,074
Medicare Patients
1,210
Medicare Billing
$75,262
Payment Breakdown by Category
Other$811,861 (53.7%)
Consulting$528,271 (35.0%)
Travel$143,659 (9.5%)
Food & Beverage$26,188 (1.7%)
Research$1,250 (0.1%)
Education$206.74 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $808,861 | 329 | 53.5% |
| Consulting Fee | $528,271 | 178 | 35.0% |
| Travel and Lodging | $143,659 | 229 | 9.5% |
| Food and Beverage | $26,188 | 330 | 1.7% |
| Grant | $3,000 | 1 | 0.2% |
| Unspecified | $1,250 | 1 | 0.1% |
| Education | $206.74 | 6 | 0.0% |
Payments by Type
General
$1.5M
1,073 transactions
Research
$1,250
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $518,056 | 411 | $0 (2024) |
| GlaxoSmithKline, LLC. | $329,903 | 188 | $0 (2024) |
| GENZYME CORPORATION | $301,469 | 179 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $128,818 | 99 | $0 (2024) |
| Genentech USA, Inc. | $98,263 | 75 | $0 (2024) |
| Merck Sharp & Dohme LLC | $17,156 | 21 | $0 (2023) |
| AstraZeneca UK Limited | $17,073 | 8 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16,800 | 13 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $14,888 | 10 | $0 (2022) |
| Circassia Pharmaceuticals Inc | $12,650 | 14 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $91,863 | 55 | GlaxoSmithKline, LLC. ($33,294) |
| 2023 | $149,650 | 76 | GlaxoSmithKline, LLC. ($67,813) |
| 2022 | $234,108 | 156 | AstraZeneca Pharmaceuticals LP ($81,683) |
| 2021 | $238,713 | 163 | GlaxoSmithKline, LLC. ($83,636) |
| 2020 | $135,672 | 90 | GlaxoSmithKline, LLC. ($44,279) |
| 2019 | $294,814 | 222 | GENZYME CORPORATION ($80,856) |
| 2018 | $226,766 | 188 | AstraZeneca Pharmaceuticals LP ($140,519) |
| 2017 | $139,851 | 124 | AstraZeneca Pharmaceuticals LP ($77,441) |
All Payment Transactions
1,074 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $805.50 | General |
| 12/03/2024 | Regeneron Healthcare Solutions, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,928.00 | General |
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | — | Travel and Lodging | In-kind items and services | $412.17 | General |
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $537.00 | General |
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Consulting Fee | Cash or cash equivalent | $537.00 | General |
| Category: Respiratory | ||||||
| 11/01/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 10/17/2024 | Shionogi Inc | — | Consulting Fee | Cash or cash equivalent | $3,300.00 | General |
| 10/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.67 | General |
| Category: Immunology | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $30.10 | General |
| 10/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Travel and Lodging | In-kind items and services | $441.35 | General |
| Category: Respiratory | ||||||
| 10/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $123.80 | General |
| Category: Respiratory | ||||||
| 10/05/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $464.64 | General |
| 10/05/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $107.51 | General |
| 10/05/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $84.03 | General |
| 10/05/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $40.16 | General |
| 09/03/2024 | AstraZeneca AB | — | Consulting Fee | Cash or cash equivalent | $2,148.00 | General |
| 07/15/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,611.00 | General |
| 07/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,643.00 | General |
| Category: Immunology | ||||||
| 06/22/2024 | Genentech USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $5,115.00 | General |
| 06/22/2024 | Genentech USA, Inc. | — | Travel and Lodging | In-kind items and services | $415.45 | General |
| 06/22/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $12.74 | General |
| 06/22/2024 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $7.46 | General |
| 06/19/2024 | AstraZeneca AB | — | Consulting Fee | Cash or cash equivalent | $1,745.25 | General |
| 06/13/2024 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,611.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study | GENZYME CORPORATION | $1,250 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 128 | 176 | $81,615 | $14,416 |
| 2022 | 3 | 109 | 135 | $67,870 | $12,492 |
| 2021 | 8 | 254 | 309 | $111,270 | $19,349 |
| 2020 | 10 | 719 | 812 | $200,430 | $29,005 |
Total Patients
1,210
Total Services
1,432
Medicare Billing
$75,262
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 56 | 80 | $30,000 | $6,436 | 21.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 19 | 34 | $39,600 | $6,115 | 15.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 17 | 19 | $7,125 | $1,519 | 21.3% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 12 | 14 | $1,330 | $139.58 | 10.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 12 | 14 | $1,610 | $103.60 | 6.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 12 | 15 | $1,950 | $102.75 | 5.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 70 | $26,250 | $5,531 | 21.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 19 | 30 | $33,150 | $5,501 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 15 | 16 | $6,000 | $1,328 | 22.1% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 17 | 19 | $2,470 | $131.97 | 5.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 15 | 46 | $50,830 | $8,449 | 16.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 40 | 53 | $19,875 | $4,322 | 21.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 26 | 28 | $10,500 | $2,124 | 20.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 13 | 13 | $4,550 | $1,117 | 24.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 15 | $3,750 | $918.15 | 24.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 15 | $3,825 | $865.03 | 22.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 11 | 12 | $3,060 | $579.50 | 18.9% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 29 | 31 | $4,030 | $220.72 | 5.5% |
| 94727 | Determination of lung volumes using gas dilution or washout | Office | 2021 | 19 | 20 | $1,900 | $207.60 | 10.9% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 29 | 30 | $3,900 | $178.00 | 4.6% |
| 94729 | Measurement of lung diffusing capacity | Office | 2021 | 19 | 19 | $2,185 | $146.30 | 6.7% |
| 94727 | Determination of lung volumes using gas dilution or washout | Facility | 2021 | 12 | 12 | $1,140 | $114.18 | 10.0% |
| 94729 | Measurement of lung diffusing capacity | Facility | 2021 | 15 | 15 | $1,725 | $107.80 | 6.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 18 | 76 | $83,980 | $14,521 | 17.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 63 | 89 | $33,375 | $5,546 | 16.6% |
About Dr. Geoffrey Chupp, MD
Dr. Geoffrey Chupp, MD is a Critical Care Medicine healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1811970577.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Geoffrey Chupp, MD has received a total of $1.5M in payments from pharmaceutical and medical device companies, with $91,863 received in 2024. These payments were reported across 1,074 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($808,861).
As a Medicare-enrolled provider, Chupp has provided services to 1,210 Medicare beneficiaries, totaling 1,432 services with total Medicare billing of $75,262. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location New Haven, CT
- Active Since 11/26/2005
- Last Updated 06/25/2008
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1811970577
Products in Payments
- DUPIXENT (Biological) $265,900
- FASENRA (Drug) $215,353
- NUCALA (Biological) $188,810
- DUPIXENT (Drug) $95,668
- FASENRA (Biological) $65,800
- TEZSPIRE (Biological) $59,210
- Xolair (Biological) $56,813
- XOLAIR (Biological) $14,888
- NIOX VERO DEVICE (Device) $12,498
- ALAIR (Device) $5,296
- CINQAIR (Drug) $3,560
- SYMBICORT (Drug) $2,690
- AIRSUPRA (Drug) $2,343
- TRELEGY ELLIPTA (Drug) $1,436
- RESLIZUMAB (Drug) $679.19
- VENOVO (Device) $140.24
- NIOX VERO (Device) $115.18
- Esbriet (Biological) $99.99
- SMARTVEST (Device) $86.69
- US Und (Device) $75.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in New Haven
Erica Herzog, Md, MD
Critical Care Medicine — Payments: $91,314
Critical Care Medicine $91,314
Mridu Gulati, Md, MD
Critical Care Medicine — Payments: $42,292
Critical Care Medicine $42,292
Danielle Antin-Ozerkis, Md, MD
Critical Care Medicine — Payments: $17,198
Critical Care Medicine $17,198
Jonathan Koff, M.d, M.D
Critical Care Medicine — Payments: $15,748
Critical Care Medicine $15,748
Carolyn Rochester, Md, MD
Critical Care Medicine — Payments: $14,501
Critical Care Medicine $14,501
Jean Paul Higuero Sevilla, M.d, M.D
Critical Care Medicine — Payments: $4,259
Critical Care Medicine $4,259